Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Boy with inoperable brain tumor gets thousands of birthday cards
Fri, 25 Jul 2014 01:21:40 GMT (USA TODAY)
Play gets redo for teen felled by brain tumor
Fri, 25 Jul 2014 22:38:25 GMT (Mundelein Review)
Foxborough boy with brain tumor receives 100000 cards, packages
Fri, 25 Jul 2014 22:22:05 GMT (Boston Globe)
Young Boy With Inoperable Brain Tumor Wishes For Cards For His Birthday
Wed, 23 Jul 2014 21:53:49 GMT (CBS Local)
Boy with brain tumor receives thousands of birthday cards
Fri, 25 Jul 2014 15:39:48 GMT (Dayton Daily News)
5-year-old with inoperable brain tumor has simple birthday request
Wed, 23 Jul 2014 16:35:52 GMT (WDIV Detroit)
Marching for Meera: Through grief, family raises awareness for pediatric brain ...
Wed, 23 Jul 2014 02:37:11 GMT (
Soccer team shows support for teammate with brain tumor
Fri, 25 Jul 2014 21:02:38 GMT (
Brain tumor causes and risk factors elude scientists
Fri, 25 Jul 2014 14:15:55 GMT (Medical Xpress)
Boy with inoperable brain tumor receives thousands of birthday cards
Fri, 25 Jul 2014 06:30:42 GMT (KVUE)

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
Dani Saleh Brain Cancer Research Fund at UCLA

The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology., a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.

It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.

Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.

Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2014 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2014 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:7/25/2014 4:33:55 PM PST]